Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 12750407.
- Also identified by PMC identifier 155048.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Toll-like receptors (TLRs) are recently discovered germline-encoded receptors on APCs that are critically important in innate immune recognition of microbial pathogens. However, their role in solid-organ transplantation is unknown. To explore this role, we employed a skin allograft model using mice with targeted deletion of the universal TLR signal adaptor protein, MyD88. We report that minor antigen-mismatched (HY-mismatched) allograft rejection cannot occur in the absence of MyD88 signaling. Furthermore, we show that the inability to reject these allografts results from a reduced number of mature DCs in draining lymph nodes, leading to impaired generation of anti-graft-reactive T cells and impaired Th1 immunity. Hence, this work demonstrates that TLRs can be activated in a transplant setting and not solely by infections. These results link innate immunity to the initiation of the adaptive alloimmune response.
Medical subject headings
- Antigens, Differentiation
- Drosophila Proteins
- Graft Rejection
- Membrane Glycoproteins
- Receptors, Cell Surface
- Receptors, Immunologic
- Transplantation Tolerance